Cite
HARVARD Citation
Hirsh-Raccah, B. et al. (n.d.). Exposure to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors and the association with neurocognitive side effects: a meta-analysis and meta-regression. European heart journal. p. . [Online].